Full cohort | Without PCa | With PCa | p | |
---|---|---|---|---|
N (%) | N (%) | N (%) | ||
n | 83 | 57 | 26 | |
Treated | 67 (81) | 41 (72) | 26 (100) | 0.002 |
Not treated due to decompensation/Childs B or C disease | 6 | 6 | 0 | |
Not treated because "No indication" according to clinician | 2 | 2 | 0 | |
Not treated because LFTs or liver enzymes either were normal, insignificantly elevated, or resolved on own | 5 | 5 | 0 | |
Unclear why not treated | 2 | 2 | 0 | |
Patient to follow up with PC physician | 1 | 1 | 0 | |
Remission | 43 (52) | 28 (49) | 15 (58) | 0.469 |
Noncompliance | 10 (12) | 6 (11) | 4 (15) | 1.000 |
Steroid median dose | 40 (IQR 40–60) | 40 (IQR 40–60) | 40 (IQR 40–55) | 0.535 |
Median time corticosteroids (months) | 12 (14.5) | 12 (IQR 5–23) | 15 (IQR 12–28) | 0.115 |
Median time to ALT normalization (months) | 1.4 (IQR 0.8-3.3) | 1.3 (IQR 0.8-3.7) | 1.6 (IQR 0.6-2.9) | 0.504 |
Relapses | 23 (27) | 12 (21) | 11 (42) | 0.380 |